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Phthalates are used industrially as plasticizers
and solvents and as stabilizers for colors and
fragrances. They are found in personal care
products, medications, paints, adhesives, and
medical equipment made with polyvinyl chlo-
ride plastics [Agency for Toxic Substances and
Disease Registry (ATSDR) 1995, 2001,
2003]. Diethyl phthalate (DEP), di(2-ethyl-
hexyl) phthalate (DEHP), butylbenzyl phtha-
late (BBzP), and di-n-butyl phthalate (DBP)
are used in personal care products (Houlihan
et al. 2002; Koo and Lee 2004). The poten-
tial effects of phthalates on human health are
not well characterized. There is a paucity of
existing data describing phthalate-associated
human health outcomes, although animal
studies have found testicular toxicity associ-
ated with phthalate exposure (Li et al. 1998;
Parks et al. 2000).
Two studies provide preliminary evidence
of associations between urinary concentrations
of monoethyl phthalate (MEP), a metabolite
of DEP, and DNA damage in human sperm
(Duty et al. 2003a), as well as relationships of
monobutyl phthalate (MBP) and monobenzyl
phthalate (MBzP) phthalate, metabolites of
DBP and BBzP, respectively, with decreased
sperm motility (Duty et al. 2003b). In a recent
epidemiologic study prenatal exposure to
MEP, MBP, MBzP, and monoisobutyl phtha-
late was associated with shortened anogenital
distance (AGD) in male infants (Swan et al.
2005). In rodent studies AGD is a sensitive
measure of prenatal antiandrogen exposure.
Despite the recent public and scientific
interest on the potential human health effects
of phthalates, routes of human exposure to
phthalates have not been adequately character-
ized. Potential routes include dietary ingestion
of phthalate-containing foods, inhalation of
indoor and outdoor air, and dermal exposure
through the use of personal care products that
contain phthalates. As far as we know, the pro-
portional contribution of phthalate-containing
personal care products to total body burden
has not been studied. Houlihan et al. (2002)
quantiﬁed phthalate levels in 72 personal care
products obtained at a supermarket in the
United States, including hair gel/hair spray,
body lotion, fragrances, and deodorant. DEP
was detected in 71% of these products, DBP
in 8%, BBzP in 6%, and DEHP in 4% of the
products tested (Houlihan et al. 2002). In a
recent study (Koo and Lee 2004), high-
performance liquid chromatography (HPLC)
was used to quantify the levels of the same four
phthalates in 102 hair sprays, perfumes,
deodorants, and nail polishes purchased at
retail stores in Seoul, Korea. DBP was detected
in 19 of the 21 nail polishes and in 11 of the
42 perfumes; DEP was detected in 24 of the
42 perfumes and 2 of the 8 deodorants.
The assertion that phthalates are absorbed
into the circulation through human skin is
physiologically plausible and is supported by
a limited number of human and animal stud-
ies (ATSDR 1995, 2001, 2003). The stratum
corneum of the epidermis regulates trans-
dermal absorption, and uptake is achieved
through passive diffusion (Howard et al.
2001). Water-soluble substances penetrate
hydrolyzed keratin, whereas lipid-soluble
substances such as phthalates, especially DEP
and other low-molecular-weight phthalates,
can dissolve into lipid materials between
keratin filaments. After penetration of the
epidermis, diffusion into the dermal and
subcutaneous layers is generally uninhibited
because of the nonselective and porous aque-
ous mediums in these layers. Substances can
then enter the systemic circulation through
venous and lymphatic capillaries. With
increased hydration, rates of absorption of
more hydrophilic compounds can be increased
3–5 times more than usual. Epidermal per-
meability also varies greatly between species
(Howard et al. 2001).
In one study dermal doses of DEHP were
administered to human volunteers over a
24-hr period, and approximately 1.8% of the
total dose was absorbed (Wester et al. 1998).
Another experiment involved the topical
application of DBP to human volunteers. The
authors determined that 68 mg would be
absorbed in 1 hr if the skin surface of the
whole body were saturated with the chemical
(Hagedorn-Leweke and Lippold 1995). In
another study human breast skin was exposed
in vitro to 14C-DEP, and average absorption
under conditions of occlusion was 3.9% com-
pared with 4.8% without occlusion at 72 hr.
However, this was much slower and less
complete compared with absorption through
rat skin (Mint et al. 1994).
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Phthalates are multifunctional chemicals used in a variety of applications, including personal care
products. The present study explored the relationship between patterns of personal care product use
and urinary levels of several phthalate metabolites. Subjects include 406 men who participated in an
ongoing semen quality study at the Massachusetts General Hospital Andrology Laboratory between
January 2000 and February 2003. A nurse-administered questionnaire was used to determine use of
personal care products, including cologne, aftershave, lotions, hair products, and deodorants. Phthalate
monoester concentrations were measured in a single spot urine sample by isotope dilution–high-per-
formance liquid chromatography coupled to tandem mass spectrometry. Men who used cologne or
aftershave within 48 hr before urine collection had higher median levels of monoethyl phthalate
(MEP) (265 and 266 ng/mL, respectively) than those who did not use cologne or aftershave (108 and
133 ng/mL, respectively). For each additional type of product used, MEP increased 33% (95% conﬁ-
dence interval, 14–53%). The use of lotion was associated with lower urinary levels of monobutyl
phthalate (MBP) (14.9 ng/mL), monobenzyl phthalate (MBzP) (6.1 ng/mL), and mono(2-ethylhexyl)
phthalate (MEHP) (4.4 ng/mL) compared with men who did not use lotion (MBP, 16.8 ng/mL;
MBzP, 8.6 ng/mL; MEHP, 7.2 ng/mL). The identiﬁcation of personal care products as contributors to
phthalate body burden is an important step in exposure characterization. Further work in this area is
needed to identify other predictors of phthalate exposure. Key words: environment, personal care prod-
ucts, phthalates, urinary metabolites. Environ Health Perspect 113:1530–1535 (2005).
doi:10.1289/ehp.8083 available via http://dx.doi.org/ [Online 18 July 2005]In vitro and animal experiments have also
indicated that phthalates are absorbed percuta-
neously (Barber et al. 1992; Deisinger et al.
1998; Elsisi et al. 1989; Melnick et al. 1987;
Mint et al. 1994; Ng et al. 1992; Scott et al.
1987). However, the mechanism explaining
differential rates of uptake is not agreed upon.
Scott et al. (1987) attributed the phthalate-
speciﬁc rates of absorption to varying degrees
of lipophilicity. Elsisi et al. (1989) observed
that the lengths of the alkyl chains were
inversely associated with the relative rates of
absorption; except for dimethyl phthalate,
DEP has the shortest alkyl chain (ATSDR
1995).
Although diester and monoester phthalates
have short biologic half-lives of approximately
6–12 hr and do not accumulate (ATSDR
1995, 2001, 2003), the frequent application of
personal care products may result in semi-
steady-state levels, making it possible to esti-
mate typical phthalate body burden from a
single urine sample (Hauser et al. 2004;
Hoppin et al. 2002). After exposure, diester
phthalates, which may be found in personal
care products, are metabolized to monoester
metabolites, the suspected toxic agents (Li et al.
1998). For this reason and to avoid contamina-
tion, monoester phthalate metabolites rather
than the parent diesters are commonly meas-
ured (Blount et al. 2000).
Our objective in the present study was to
determine whether the use of personal care
products predicted urinary levels of phthalate
monoesters, and to identify subject character-
istics that predicted phthalate levels.
Materials and Methods
Design and setting. This study was approved
by the Human Subject Committees at 
the Harvard School of Public Health,
Massachusetts General Hospital (MGH), and
Simmons College. All subjects signed an
informed consent. Subjects were participants
in an ongoing study on phthalates and male
reproductive health. They were recruited
between January 2000 and February 2003
from the Andrology Laboratory at MGH.
Males between 20 and 54 years of age who
were partners of subfertile couples were eligi-
ble; those who have had a vasectomy were
excluded. Approximately 65% of eligible men
agreed to participate. The most frequently
cited reason for not participating was lack of
time. A total of 406 men were recruited.
Personal care product use assessment. A
trained research nurse administered a brief
questionnaire to each subject at the time of his
visit to the MGH andrology clinic for semen
and urine sample collection. Information was
obtained on personal care product use, smoking
status, age, height, weight, race, and use of
medications. Participants were speciﬁcally asked
whether they had used hair gel/hair spray,
lotion, aftershave, cologne, or deodorant in the
48 hr before the collection of the urine sample.
They were also asked to record the time they
last used the products within the 48-hr period.
Urinary phthalate monoester measure-
ment. A single spot urine sample was collected
from each participant in a sterile plastic speci-
men cup (which was prescreened for phtha-
lates) on the same day that the questionnaire
was administered. The analytical approach has
been described in detail (Blount et al. 2000)
and adapted to both enable the detection of
additional monoesters and improve efﬁciency
of the analysis (Silva et al. 2003). Brieﬂy, meas-
urement of monoester metabolites, namely,
MEP, MBP, mono(2-ethylhexyl) phthalate
(MEHP), MBzP, and monomethyl phthalate
(MMP), entailed enzymatic deconjugation of
the phthalates from their glucuronidated form,
solid-phase extraction, HPLC separation, and
tandem mass spectrometry detection. The lim-
its of detection (LODs) were approximately
1 ng/mL. One method blank, two quality con-
trol samples (human urine spiked with phtha-
late monoesters), and two sets of standards
were analyzed along with every 21 unknown
urine samples. Analysts at the Centers for
Disease Control and Prevention (CDC) were
blind to all information concerning subjects.
To control for urinary dilution, urinary
concentrations were adjusted according to spe-
cific gravity. Specific gravity was measured
using a handheld refractometer (National
Instrument Company Inc., Baltimore, MD).
The following formula was used to adjust
phthalate concentrations by specific gravity:
Pc = P[(1.024 – 1)/SG – 1], where Pc repre-
sents specific gravity–corrected phthalate
concentration (ng/mL), P is the measured
phthalate concentration (ng/mL), and SG is
the specific gravity of the sample. Specific
gravity–adjusted monoester phthalate levels
were used as continuous outcome variables in
statistical models.
Statistical methods. All analyses were per-
formed using SAS software (version 8.1; SAS
Institute Inc., Cary, NC). The use of each per-
sonal care product was categorized into a
dichotomous variable (yes/no use in the 48 hr
before the urine sample collection).
Because the phthalate monoester levels
were not normally distributed, nonparametric
tests were used to assess univariate associations
between personal care product use and urinary
phthalate levels. Multiple linear regression was
used to explore the relationship between each
of the ﬁve personal care products and each of
the ﬁve log-transformed monoester phthalate
concentrations. In addition, a six-level sum
variable was created, representing the number
of different types of products used by a partici-
pant in the past 48 hr; possible values for this
variable were 0, 1, 2, 3, 4, or 5. To determine
if a dose–response relationship existed between
urinary phthalate levels and the number of
types of personal care products used, a trend
test was performed using sum variable as an
ordinal variable. For urinary phthalate concen-
trations that were below the LOD, a value
equal to half the LOD was imputed (except
when quantification was given) as follows:
MEP, 0.605 ng/mL; MBzP, 0.235 ng/mL;
MBP, 0.47 ng/mL; MEHP, 0.435 ng/mL; and
MMP, 0.355 ng/mL.
After evaluating appropriateness using qua-
dratic terms, we modeled age and body mass
index (BMI; kilogram per square meter) as
continuous independent variables. Smoking
status was categorized as current smoker and
current nonsmoker (includes ex-smokers and
never smokers). Race was coded as African
American, Hispanic, and other race, with
Caucasian as the reference group. On the basis
of biologic plausibility and statistical factors
(i.e., change in parameter estimate), we
included age, BMI, race, and smoking variables
in all models as potential confounders.
To explore the relationship between time
of product use and urinary levels of the
phthalates, we regressed log-phthalate levels on
the time between product use and urine sam-
ple collection (referred to as TIMEDIF).
TIMEDIF was categorized into four intervals:
product use 0–3 hr before urine sample
collection (TIME0–3); > 3 but ≤ 6h r
(TIME3–6); > 6 but ≤ 8 hr (TIME6–8), and
> 8 hr (TIME9). Approximately 75–85% of
subject’s product use was within 8 hr of urine
collection, and therefore we used TIMEDIF >
8 hr as the reference category.
Results
Subject demographics. Of the 406 men
recruited for an ongoing semen quality study,
37 did not provide urine samples. Of the
remaining 369, speciﬁc-gravity analyses were
not available for 32, leaving 338 for primary
analysis. Additionally, one urine sample was
missing MMP concentrations. The study
population was composed largely of white (n =
275, 82%), nonsmoking men (n = 304, 91%)
(Table 1). There were 19 African-American
men, 18 Hispanic men, and 24 men of other
race/ethnicity.
Personal care product use. Eleven men
(3%) did not provide complete product use
information (Table 1). Most men reported use
of deodorant (89%), whereas fewer men
reported using hair gel (37%), lotion (34%),
cologne (29%), and aftershave (13%). Nine
men (2.7%) did not use any of the personal
care products listed on the questionnaire, 114
(33.7%) used only one type of product, 119
(35.3%) used two types of products, 71 (21%)
used three types of products, 22 (6.5%) used
four different types of products, and only
3 (0.9%) of the men used ﬁve or more differ-
ent types of products within 48 hr of urine
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American (59%) and Hispanic (53%) men
who reported using cologne within 48 hr of
urine collection was higher the percentage of
Caucasian men (25%) or men of other races
(25%). Additionally, African-American men
(65%) were more likely than Hispanic (44%),
Caucasian (30%), or men of other races
(43%) to use lotion. No other associations
were seen between any other personal care
products and race. Interestingly, men who
used aftershave were almost twice as likely
(18.5%) to also use cologne as non-aftershave
users (9.8%) (chi squared p = 0.03). There
were no consistent relationships among any of
the other products used.
Urinary phthalate monoesters. There was a
wide distribution of both specific gravity–
adjusted (Table 2) and -unadjusted phthalate
monoester levels (Table 3). Five phthalate
monoesters were detected in 75–100% of sub-
jects. MEP was the most prevalent (100%), fol-
lowed by MBP (95%) and MBzP (90%).
MEHP and MMP were both found in about
75% of subjects. Phthalate metabolite concen-
trations are presented both adjusted for speciﬁc
gravity and unadjusted for comparison with
other studies. The highest geometric mean
levels were found for MEP (179 ng/mL),
followed by MBP (16.6 ng/mL), MBzP
(7.1 ng/mL), MEHP (6.6 ng/mL), and last,
MMP (4.5 ng/mL). 
Covariate relationships. Race and cigarette
smoking status were predictors of MEP and
MBP levels (Table 4). We found signiﬁcantly
higher median MEP levels among African-
American men (506 ng/mL) and Hispanic men
(395 ng/mL) compared with Caucasian men
(140 ng/mL) and those men categorized as
other race (125 ng/mL). Median MBP levels 
in Caucasian men (15.3 ng/mL) were also
lower than among African-American men
(32.7 ng/mL) and Hispanic men (29.1 ng/mL),
and among men identified as other race
(26.5 ng/mL). Median MEP levels in current
smokers (250 ng/mL) were signiﬁcantly higher
than among nonsmokers (143 ng/mL)
(Table 4). BMI was weakly, although posi-
tively, correlated with MEP (Spearman correla-
tion coefﬁcient of 0.1, p < 0.05). Age was not
associated with any of the ﬁve phthalate con-
centrations. Wilcoxon rank-sum tests showed
positive associations between the sum variable
for product use and African-American men and
men of other races compared with Caucasians.
BMI was positively associated with those identi-
ﬁed as other race.
Product use and urinary phthalate rela-
tionship. In the univariate analyses, median
MEP levels were higher among cologne users
(265 ng/mL) compared with those who did
not use cologne (108 ng/mL). Likewise, men
who used aftershave had higher median MEP
levels (266 ng/mL) than men who did not
(133 ng/mL). Fragranced products such as
cologne and aftershave contain relatively
higher DEP levels than other personal care
products. Figure 1, created on a subset of men
who used cologne plus additional products,
depicts the rise in MEP levels with specific
combinations of personal care product use.
Median MBP was lower among men who
had used deodorant (16.3 ng/mL) compared
with those who did not use deodorant
(22.5 ng/mL). The use of lotion was associ-
ated with lower median levels of MBP
(14.9 ng/mL), MBzP (6.1 ng/mL), and
MEHP (4.4 ng/mL) compared with men who
did not use lotion (MBP, 16.8 ng/mL; MBzP,
8.6 ng/mL; MEHP, 7.2 ng/mL) (Table 5).
Men of Hispanic, Caucasian, and other
races who used cologne had considerably higher
median MEP levels (981, 444, and 178 ng/mL,
respectively) than non-cologne users of similar
race (138, 102, and 116 ng/mL; p = 0.09,
< 0.001, and 0.13, respectively). Interestingly,
African-American men who used cologne had
30% lower median MEP levels compared with
non-cologne users (371 ng/mL vs. 508 ng/mL),
although the differences were not statistically
signiﬁcant. Hispanic and Caucasian men had
substantially higher MEP levels if they used
aftershave (1076 and 220 ng/mL) than if they
did not (138 and 126 ng/mL; p = 0.08 and
0.03, respectively). African-American men
who used aftershave had 33% lower MEP lev-
els compared with non-aftershave users
(340 ng/mL vs. 508 ng/mL), although the dif-
ferences were not statistically significant. No
other race/product associations were observed.
Duty et al.
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Table 3. Distribution of unadjusted urinary levels of phthalate monoesters: percentiles and summary statistics
(ng/mL).
Percentile Geometric
Phthalate n 5th 25th 50th 75th 95th Mean ± SD mean
MEP 338 17.0 48.5 145 457 1,953 485 ± 1,008 164
MEHP 338 < LOD 1.9 5.2 18.4 134.6 25.6 ± 60.1 6.0
MBP 338 2.2 7.8 14.5 31.7 75.1 85.6 ± 932.8 14.9
MBzP 338 < LOD 2.9 6.8 14.1 41.3 13.90 ± 32.4 6.0
MMP 337 < LOD 1.7 4.5 10.1 31.3 11.0 ± 31.6 4.1
LODs (ng/mL): MEP, 1.21; MBzP, 0.47; MBP, 0.94; MEHP, 0.87; MMP, 0.71.
Table 4. Median (25th and 75th percentiles) urinary levels of phthalate monoesters (ng/mL)a by race and
smoking status.
MEP MEHP MBP MBzP MMP
Race
Black 506* (294, 1,134) 7.4 (3.9, 8.7) 32.7* (18.1, 42.5) 10.7 (6.8, 21.4) 6.0 (2.0, 12.0)
Hispanic 395* (83.3, 1,076) 5.6 (3.3, 20.7) 29.1* (17.3, 42.4) 12.2 (3.5, 19.5) 5.2 (1.9, 11.9)
Other 125 (40.3, 218) 7.1 (1.7, 10.8) 26.5* (7.1, 38.4) 6.4 (2.3, 11.9) 4.6 (2.0, 11.3)
White 140 (56.6, 469) 6.2 (2.3, 20.7) 15.3 (9.9, 26.9) 7.4 (4.0, 14.2) 7.3 (3.3, 11.3)
Smoking
Yes 250* (96.5, 826) 5.0 (1.8, 12.6) 20.9 (10.8, 46.9) 8.0 (4.3, 17.4) 8.5 (4.6, 18.2)
No 144 (57.5, 465) 6.4 (2.5, 19.6) 16.3 (10.3, 30.0) 7.7 (4.0, 14.2) 4.5 (2.1, 10.4)
aSpeciﬁc gravity–adjusted phthalate levels. *Univariate regression analysis p ≤ 0.05; reference group for race is whites.
Table 2. Distribution of speciﬁc gravity–adjusted urinary levels of phthalate monoesters: percentiles and
summary statistics (ng/mL).
Percentile Geometric
Phthalate n 5th 25th 50th 75th 95th Mean ± SD mean
MEP 338 24.5 58.2 154 503 2,030 490 ± 979 179
MEHP 338 < LOD 2.4 6.3 19.1 116.1 27.6 ± 69.1 6.6
MBP 338 3.1 10.3 16.5 30.6 68.2 76.2 ± 798.4 16.6
MBzP 338 < LOD 4.0 7.7 14.1 39.7 14.0 ± 34.6 7.1
MMP 337 < LOD 2.1 4.8 11.4 32.1 10.8 ± 22.8 4.5
LODs (ng/mL): MEP, 1.21; MBzP, 0.47; MBP, 0.94; MEHP, 0.87; MMP, 0.71.
Table 1. Characteristics of study subjects (n = 338).
Characteristic Value
Age [median (25%, 75%)]  35.0 (32.0, 39.1)
BMI [median (25%, 75%)] 27.5 (25.0, 30.6)
Racea [n (%)]
White 275 (82)
Black/African American 18 (5)
Hispanic 19 (6)
Other 24 (7)
Smokingb [n (%)]
Current smoker 31 (9)
Nonsmoker (ex- and never smoker) 304 (91)
Use of personal care products [n (%)]
Lotionc 110 (34)
Hair gel/hair sprayd 121 (37)
Aftershavee 42 (13)
Deodorantf 299 (89)
Cologneg 94 (29)
aRace data missing for 2 men. bSmoking data missing for 3
men. cLotion use data missing for 11 men. dHair gel/hair
spray data missing for 7 men. eAftershave data missing for
8 men. fDeodorant data missing for 1 man. gCologne data
missing for 8 men.Multiple linear regression. In multiple lin-
ear regression models, after adjusting for race,
smoking status, BMI, and age, urinary levels of
MEP were 2.57 times higher among men who
had used cologne and 1.71 times higher among
aftershave users compared with men who did
not report the use of these products (p < 0.0001
and 0.02, respectively) (Table 6). There was
also a dose–response relationship between uri-
nary phthalate MEP levels and the number of
types of personal care products used. For every
additional type of product used, MEP concen-
trations increased 33% (95% conﬁdence inter-
val, 14–53%; trend test p = 0.0002) (Figure 2).
The use of deodorant was associated with 30%
lower MBP levels (p = 0.08). MBP, MBzP, and
MEHP levels were 31% (p = 0.004), 34% (p =
0.003), and 34% (p = 0.003) lower, respec-
tively, among men who had used lotion within
the past 48 hr before urine collection compared
with men who had not.
Time of product use. In secondary analy-
ses, we explored the relationship between time
of product use and urinary levels of phthalate
monoesters. Statistical power was limited in
these secondary analyses as a result of small
sample sizes, generally fewer than 15 subjects
for each of the four TIME strata. The analyses
were performed only among users of each spe-
cific product. Cologne use at TIME0–3,
TIME3–6, and TIME6–8 compared with
cologne use at TIME9 was associated with an
increase in MEP of 1.7-fold (p = 0.17),
2.8-fold (p < 0.01), and 1.1-fold (p = 0.75),
respectively. No consistent time trends were
observed for the other phthalates and cologne
use. Aftershave was inconsistently associated
with a 2- to 3-fold increase in MEP levels—
3.0-fold increase at TIME0–3 (p = 0.15),
2.0-fold increase at TIME3–6 (p = 0.25), and
2.6-fold increase at TIME6–8 (p = 0.11)—
compared with aftershave use at TIME9. No
time trends were observed for the other phtha-
lates and aftershave use. For lotion use at
TIME0–3, TIME3–6, and TIME6–8, MBP
concentration increased 1.9-fold (p = 0.03),
1.2-fold (p = 0.55), and 1.2-fold (p = 0.52)
compared with lotion use at TIME9. No sig-
nificant time relationships were found
between lotion use and any other phthalate or
between deodorant or hair gel use and any of
the phthalates.
Discussion
In the present study, men who used cologne
and/or aftershave within the 48-hr period
before the collection of the urine sample had
higher urinary levels of MEP. This is not unex-
pected because previous studies have demon-
strated that DEP, the parent compound of
MEP, is an ingredient in many colognes,
deodorants, and fragranced products (Houlihan
et al. 2002; Koo and Lee 2004) and that percu-
taneous absorption of DEP occurs (Api 2001;
ATSDR 1995; Mint et al. 1994; Scott et al.
1987). More striking is the steepness of the
dose–response relationship between the num-
ber of product types used in the 48 hr before
urine collection and urinary MEP levels. DEP
was found in 71% of the personal care products
tested in one study (Houlihan et al. 2002),
whereas DEHP, DBP, and BBzP were found in
fewer than 10% of products. In another study,
DEP was found in 57% of the perfumes and
25% of the deodorants surveyed; DBP, DEHP,
and BBzP were not detected in any of the
deodorants and in fewer than 27% of the per-
fumes (Koo and Lee 2004). Therefore, it is
plausible that MEP would have a strong rela-
tionship with multiple product use, whereas the
other phthalate monoesters would not.
Interestingly, the use of body lotion was
associated with lower levels of MBP, MBzP,
and MEHP. The reason for this relationship is
not known, although several hypotheses are
plausible. It is possible that other ingredients in
body lotion may act as a barrier to the absorp-
tion of DBP, BBzP, and DEHP. It is also feasi-
ble that men who use lotion use fewer other
personal care products. However, chi-squared
tests did not show signiﬁcant inverse relation-
ships between the use of body lotion and other
products (data not shown). An alternative
explanation is that the urinary levels of these
monoesters reflect exposure to their parent
phthalates other than by use of personal care
products. Percutaneous absorption after der-
mal exposure is expected to be lower for DBP,
BBzP, and DEHP than for DEP.
The quantities of phthalates present in dif-
ferent brands of deodorant, aftershave, hair
gel/hair spray, lotion, and cologne are known
to be quite variable (Houlihan et al. 2002; Koo
and Lee 2004). In the present study, because
information on the use of speciﬁc brand name
products was not gathered, the analysis was
Predictors of urinary phthalate levels
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Figure 1. Specific-gravity–adjusted urinary MEP concentration according to combinations of product
types used. Data points represent medians; error bars represent 25th and 75th percentiles.
Table 5. Median (25th and 75th percentiles) urinary levels of phthalate monoesters (ng/mL)a by personal
care products used 48 hr before urine sample collection.
MEP MEHP MBP MBzP MMP
Lotion
Yes 136 (60.0, 438) 4.6* (1.6, 11.5) 15.7* (8.5, 28.1) 6.1* (3.0, 11.5) 4.2 (2.0, 10.4)
No 160 (56.6, 528) 7.2 (2.7, 20.4) 16.8 (10.3, 31.7) 8.6 (4.6, 15.1) 5.1 (2.4, 12.1)
Cologne
Yes 422* (155, 1076) 5.3 (1.8, 16.9) 18.6 (12.2, 33.6) 10.5 (4.6, 16.7) 4.7 (2.6, 13.2)
No 110 (48.0, 293) 6.6 (2.5, 19.1) 15.4 (9.6, 29.2) 6.8 (3.9, 13.8) 4.9 (2.1, 10.3)
Deodorant
Yes 165 (60.4, 534) 6.1 (2.4, 20.7) 16.3 (10.3, 29.2) 7.7 (4.0, 14.2) 4.7 (2.0, 11.3)
No 91.4 (36.4, 323) 6.3 (2.2, 13.7) 22.5 (10.8, 39.0) 7.5 (4.9, 14.0) 6.9 (2.6, 12.6)
Aftershave
Yes 266* (123.2, 625) 6.1 (2.7, 13.8) 17.9 (10.9, 33.6) 7.9 (4.2, 16.2) 4.8 (2.4, 8.6)
No 135 (54.5, 477) 6.3 (2.3, 18.9) 16.3 (10.2, 30.2) 7.6 (3.9, 14.1) 4.8 (2.1, 12.0)
Hair gel/spray
Yes 182 (57.8, 547) 7.7 (2.6, 21.6) 16.0 (8.9, 24.5) 8.0 (4.2, 14.2) 4.9 (2.0, 11.4)
No 139 (58.2, 464) 5.9 (2.1, 14.6) 16.7 (11.1, 31.7) 7.6 (4.0, 14.2) 4.8 (2.3, 11.7)
aSpeciﬁc-gravity–adjusted phthalate levels. *p ≤ 0.05 in multivariate linear regression models adjusted for age, BMI, race,
and smoking.performed by category of product. This
approach is likely to introduce bias toward the
null because not all products within a given
category contain phthalates and those that do
contain phthalates do so at variable concentra-
tions. Because the participants in this study are
all male, it is unclear whether the ﬁndings of
this study may be generalizable to women,
who may use different types and combinations
of personal care products.
It is unclear why current smokers had
higher levels of MEP. The results, however,
were unstable because the sample size was
small: only 31 men (9%) were current smok-
ers. One potential explanation is that smoking
may alter the toxicokinetics of DEP. Although
DBP, unlike DEP, is listed as an ingredient in
the ﬁlters of Phillip Morris cigarettes (Phillip
Morris 2004), MBP was not found to be
related to current smoking status.
Racial differences in urinary levels of MEP
and MBP were consistent with previous data
from the National Health and Nutrition
Examination Survey (NHANES) 1999–2000
that have shown African Americans and
Hispanics have higher urinary levels of MEP
and MBP than do Caucasians (CDC 2003;
Silva et al. 2004). In our study we explored the
MEP and race associations for use of speciﬁc
personal care products. The higher MEP levels
for Hispanic than for Caucasian men appeared
related to differentially higher cologne and
aftershave use. Interestingly, the higher urinary
MEP levels in African-American than in
Caucasian men did not appear to be related to
higher cologne and/or aftershave use.
Therefore, the use of other products not identi-
ﬁed in this study, different sources of exposure
to DEP, or differential toxicokinetics may be
driving the high MEP levels among African-
American men. After accounting for race, age,
and smoking status in the statistical models,
MEP levels were still signiﬁcantly higher among
cologne and aftershave users; African-American
race remained an independent predictor of
MEP levels. However, it is important to note
that only 18 African Americans participated in
the study, and these ﬁndings may be related to
chance because of the small numbers. Further
study on racial/ethnic differences is warranted.
In an earlier study on the relationship
between demographic characteristics and uri-
nary phthalate levels among a nonrepresenta-
tive subset of 289 participants of NHANES
III, MBP, MBzP, and MEHP were higher in
individuals of low socioeconomic status (Koo
et al. 2002). Urban residence was also signiﬁ-
cantly associated with higher MEHP and MBP
levels. Socioeconomic status and area of resi-
dence were not controlled for in the present
study, and these factors could potentially
account for some of the differences measured
between the racial groups. Finally, it is also
possible that higher personal care product use
or the selection of certain types of products
among racial groups may contribute to differ-
ences in urinary phthalate levels.
The time elapsed between product use and
urine sample collection inﬂuenced the relation-
ship between cologne use and MEP concen-
trations. MEP was 2.7-fold higher when
cologne was used between 3 and 6 hr before
urine collection compared with when it was
used 8 hr or more before urine collection.
Therefore, to best assess the relationship of
cologne use on urinary MEP levels, we suggest
that urine collection should occur 3–6 hr after
cologne use.
When time of lotion use was not
accounted for in the analysis, there was an
inverse association between urinary levels of
MBP and lotion use. However, in analyses in
which time of use was explored, MBP concen-
trations were significantly higher within the
ﬁrst 3 hr after lotion use compared with lotion
use 8 hr or more before. The lotion use MBP
relationship may require a larger data set to
determine how use correlates with MBP levels
in urine samples collected at variable times
after applying lotion.
Although aftershave use between 0 and 8 hr
before urine collection was associated with 2- to
3-fold higher MEP concentration compared
with aftershave use more than 8 hr before
urine collection, each strata had fewer than
10 subjects, and the reference group had only
15. This could explain why the aftershave–
time of use relationships did not reach statistical
signiﬁcance.
To put these findings into perspective, a
comparison with previous work is offered. The
interquartile difference (443 ng/mL) in MEP,
associated with increased DNA damage in
sperm (Duty et al. 2003b), was approximately
2- to 3-fold higher than the difference in levels
of MEP observed between men who did versus
those who did not use cologne (312 ng/mL) or
aftershave (131 ng/mL), respectively. MBP and
MBzP, found in our previous study to be asso-
ciated with decreased sperm motility and con-
centration (Duty et al. 2003b), were not found
to be associated with aftershave or cologne use.
Conclusions
Cologne and aftershave use were associated
with significantly higher urinary MEP levels
after controlling for age, BMI, smoking, and
race. Additionally, a dose–response relation-
ship was found between the number of differ-
ent types of personal care products used and
MEP urinary concentrations. Interestingly,
lotion was inversely associated with most
Duty et al.
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Figure 2. Specific-gravity–adjusted urinary MEP concentrations according to number of product types
used. Data points represent medians; error bars represent 25th and 75th percentiles.
Table 6. Multiplicative factorsa (95% conﬁdence interval) for a change in urinary phthalate monoester levelb
associated with use of personal care products within the past 48 hr (n = 323).
Product type MEP MEHP MBP MBzP MMP
Lotion 0.97 (0.70–1.33) 0.66 (0.44–0.99) 0.69 (0.53–0.88) 0.66 (0.50–0.87) 0.92 (0.66–1.29)
Cologne 2.57 (1.88–3.53) 0.96 (0.63–1.46) 1.06 (0.82–1.38) 1.16 (0.88–1.54) 1.19 (0.84–1.67)
Deodorant 1.24 (0.75–2.05) 1.23 (0.65–2.34) 0.70 (0.47–1.04) 0.95 (0.62–1.47) 0.94 (0.55–1.59)
Aftershave 1.71 (1.10–2.64) 0.93 (0.53–1.64) 1.00 (0.70–1.43) 1.16 (0.80–1.69) 0.97 (0.61–1.55)
Hair gel 1.15 (0.85–1.57) 1.23 (0.83–1.81) 0.92 (0.72–1.17) 0.95 (0.73–1.24) 0.99 (0.72–1.35)
aAll models are adjusted for age, BMI, smoking, and race. Multiplicative factors represent multiplicative changes in
phthalate levels associated with use of speciﬁc personal care products within the past 48 hr after back-transformation of
phthalate concentrations: 1.0, no change in urinary phthalate level; < 1.0, multiplicative decrease in phthalate level; > 1.0,
multiplicative increase in phthalate level. bIn all models, log transformations of specific gravity–adjusted phthalate
concentrations were used.Predictors of urinary phthalate levels
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phthalate levels. Secondary analysis revealed
that, for cologne, product use 3 to 6 hr before
urine collection was most predictive of urinary
MEP concentration. However, for lotion,
product use in the 3 hr before urine collection
was most predictive for MBP concentration.
The identiﬁcation of personal care products
as contributors to phthalate body burden is an
important step in exposure characterization.
Additionally, the results of this study suggest
that the time that products are used in relation
to the time that the urinary samples are col-
lected should be documented. This will help
reduce random measurement error in statistical
analysis. Further work is needed to identify
additional predictors of phthalate exposure.
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